♟️ Monday 26 October 2026 Mon, 26 Oct 2026

ReNerve has reported its strongest quarter yet, with sales climbing to $584,000 as the medical device company expands across Asia-Pacific. The growth came alongside a secured funding drawdown, leaving the company with $1.62 million in cash but continued negative operating cash flow.

Challenger’s board has rejected TAL Daiichi Life Australia’s indicative $11.80-per-share takeover proposal as too low to recommend, while leaving the door open to a revised offer. No binding transaction has been agreed and shareholders have no action to take at this stage.

Falcon Metals has extended the Blue Moon mineralised system to 850 metres, with high-grade results from the Jasmine and Lotus zones and a fifth gold-bearing zone emerging. A A$30 million placement has left the explorer with A$38.1 million in cash to pursue drilling across Victoria and Western Australia.

Bubalus Resources will acquire the 494-square-kilometre Skyline copper-gold project in western Tasmania, close to the Mt Lyell mine, in a deal that could reshape its exploration portfolio. Completion depends on an approximately A$2.835 million capital raising, approvals and tenure conditions.

Lindian Resources says its Kangankunde rare earths project remains on track for first monazite concentrate production in December, with equipment testing and export preparations now underway. The company also reported $45 million in cash, full ownership of its Kazakhstan processing plant and a newly disclosed appeal of a previously dismissed Malawi court case.

Arika Resources has identified a previously unrecognised gold lode at its Kookynie project after drilling returned 19 metres at 7.99g/t gold, including 6 metres at 15.87g/t. The early-stage discovery sits above the historic Champion Main Reef and opens several follow-up targets along a 3km mineralised trend.

AdAlta is nearing two important development milestones for its EW-001 CAR-T therapy, with a US FDA pre-IND meeting scheduled for 4 November and Australian manufacturing runs expected before year-end. The progress comes with encouraging but early Chinese clinical data, while cash of A$0.65 million leaves limited room for delay.

Zeotech has begun an approximately 800-tonne commercial-scale AusPozz production trial while reporting independently replicated mining test results and a 92% average methane reduction in treated landfill cells. The September quarter also brought a non-binding VINCI Construction MOU, further Toondoon resource work and A$6.609 million in cash.

Stellar Resources has lifted its Heemskirk tin inventory to 115.3kt of contained tin, while post-quarter drilling has identified mineralisation outside the Severn resource that could connect with the high-grade Montana deposit. The company is now folding those possibilities into a prefeasibility study targeted for the first half of 2027.

Invex Therapeutics has agreed to acquire New Zealand biotech Rekover Therapeutics for shares and performance rights, adding a planned Phase 2a multiple sclerosis trial to its neurology portfolio. The transaction is paired with a $10 million placement, but would substantially expand the company’s share count and requires shareholder approval.

Western Mines Group has increased the Mulga Tank resource to 2.647 billion tonnes at 0.27% nickel, containing 7.2 million tonnes of nickel. The major exploration milestone now faces its more consequential test: whether a large, low-grade and unconstrained resource can support an economic mine.

Pinnacle Minerals has agreed to acquire an option over five early-stage Utah tungsten projects and plans to raise up to A$1.3 million to fund the move. The deal would reshape the company’s US exposure, board and capital structure, but remains subject to shareholder approval and several title, access and funding conditions.

Island Pharmaceuticals has secured approvals to use Galidesivir in Uganda’s Bundibugyo Ebola outbreak while advancing two complementary Marburg studies and expanding manufacturing. The progress comes with a sharper funding question: cash fell to A$7.83 million after quarterly operating outflows of A$4.93 million, leaving an estimated 1.6 quarters of funding.

Anax Metals has moved its Whim Creek copper-zinc project deeper into engineering and financing work, while Mons Cupri’s Mineral Resource rises 24% to 6.32 million tonnes. The company is still targeting a fourth-quarter Final Investment Decision, but funding remains non-binding and the larger resource has yet to enter the project’s Ore Reserve or financial forecasts.

Elementos has secured approval for the 8.1km access corridor at its Oropesa tin project in Spain and made its Robledollano smelter option unconditional. The company ended September with A$38.6 million in cash, but still needs primary permits, financing and offtake agreements before a final investment decision.

Manhattan Gold has completed its largest-ever Hook Lake drilling campaign, with strong gold results at Jaws and polymetallic sulphide intercepts at Spectre widening the project’s exploration case. But five assays remain outstanding, the next funding tranche still needs shareholder approval, and the company reports only 1.54 quarters of cash coverage on its current spending basis.

Lotus Resources has secured the final major approval needed to move its first Kayelekera uranium shipment through Malawi, Zambia and Namibia. About 145,000 pounds of U3O8 is expected to leave site within a week, with shipment from Walvis Bay targeted for November.

Avira Resources has completed its 4,234-metre Mt Cattlin drilling campaign, with assays still pending from first-pass holes at the historically high-grade Sirdar and Ellendale prospects. The exploration momentum comes alongside $860,000 in cash and an estimated 1.45 quarters of funding.

Syrah Resources is set to receive a further US$15 million from the US International Development Finance Corporation before the end of October, providing working and sustaining capital for its Balama graphite operation. The funding comes with a temporary waiver of existing loan defaults, new warrants and no guarantee of further disbursements.

OFX’s proposed $1.00-per-share takeover by Equals has lost its exclusivity after the UK bidder failed to reconfirm its proposal by the agreed deadline. Meanwhile, quarterly net operating income improved sequentially but remained well below the prior year, with enterprise revenue falling sharply and available cash declining.

Electro Optic Systems has expanded its defence pipeline sharply, with an unconditional A$717 million order book and a conditional Kuwait contract that could add about A$700 million. The opportunity comes with substantial guarantee, working-capital and export-licensing requirements.

6K Additive delivered 61% year-on-year revenue growth in the September quarter as its order backlog jumped 52% to US$18.1 million. The company is pairing that demand with a funded manufacturing expansion, but the next test is converting commitments into production and cash.

88 Energy has secured more than 80% of the services and long-lead items needed for its planned Augusta-1 well, while several bids have emerged for a South Prudhoe farm-out. The progress comes with A$5.0 million in cash and a reported 2.85 quarters of funding based on current outgoings.

AML3D has secured an approximately $2.2 million order from Northrop Grumman Marine Systems for a large-scale ARCEMY X metal additive manufacturing system. The contract gives AML3D its first engagement with the US defence prime and expands its contracted US base to 17 ARCEMY systems.